BackAmylyx Pharmaceuticals Overview
Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals Target Price

Where could AMLX trade next? Consensus target price: $44.

Get informed when a big investor buys or sells

+ Follow

Share Price

$28.04

Average Target Price

$44.3058% upside

10 analysts in the last 4 months

High: $57 | Low: $24

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-27GuggenheimSeamus Fernandez$57103.3% upsideOpen
2026-08-19Guggenheim$5596.1% upsideOpen
2026-08-18Mizuho SecuritiesGraig Suvannavejh$4249.8% upsideOpen
2026-08-18Robert W. Baird$5285.4% upsideOpen
2026-08-18H.C. WainwrightAndrew Fein$5596.1% upsideOpen
2026-08-18UBS$5596.1% upsideOpen
2026-08-18UBS$4560.5% upsideOpen
2026-08-17Mizuho SecuritiesGraig Suvannavejh$307% upsideOpen
2026-08-07Robert W. Baird$280.1% downsideOpen
2026-07-20Mizuho SecuritiesGraig Suvannavejh$2414.4% downsideOpen
2026-06-25Guggenheim$4042.7% upsideOpen
2026-06-08H.C. WainwrightAndrew Fein$3421.3% upsideOpen
2026-04-28Mizuho SecuritiesGraig Suvannavejh$2125.1% downsideOpen
2026-02-19Mizuho Securities$1932.2% downsideOpen
2026-02-10H.C. WainwrightAndrew Fein$280.1% downsideOpen
2025-10-29Mizuho Securities$1642.9% downsideOpen
2025-10-16Robert W. BairdJoel Beatty$1932.2% downsideOpen
2025-09-15GuggenheimSeamus Fernandez$2510.8% downsideOpen
2025-06-24GuggenheimSeamus Fernandez$1739.4% downsideOpen
2025-05-06Leerink PartnersMarc Goodman$1064.3% downsideOpen
2024-11-18Robert W. BairdJoel Beatty$1160.8% downsideOpen
2024-10-23Bank of America SecuritiesGeoff Meacham$1064.3% downsideOpen
2024-10-18H.C. WainwrightAndrew Fein$871.5% downsideOpen
2024-10-18Leerink PartnersMarc Goodman$485.7% downsideOpen
2024-05-14Mizuho SecuritiesGraig Suvannavejh$389.3% downsideOpen
2024-04-11Robert W. BairdJoel Beatty$389.3% downsideOpen
2024-04-04Deutsche BankNeena Bitritto-Garg$485.7% downsideOpen
2024-03-17Mizuho SecuritiesGraig Suvannavejh$485.7% downsideOpen

Amylyx Pharmaceuticals (AMLX) FAQ

Amylyx Pharmaceuticals posts a target price of $44. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $44 for AMLX means covering analysts, on average, see the stock 58.0% upside of $28.04 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for AMLX's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Amylyx Pharmaceuticals's other metric pages and overview cover the third.